Arielle Kanters1, Andrew J Mullard2, Jennifer Arambula2, Laurie Fasbinder2, Greta Krapohl2, Sandra L Wong3, Darrell A Campbell2, Samantha Hendren4. 1. Department of Surgery, University of Michigan Health System, Ann Arbor, MI, United States. Electronic address: akanters@med.umich.edu. 2. Michigan Surgical Quality Collaborative, Ann Arbor, MI, United States. 3. Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States. 4. Department of Surgery, University of Michigan Health System, Ann Arbor, MI, United States.
Abstract
OBJECTIVE: Surgery remains the cornerstone therapy for colorectal cancer (CRC). This study assesses CRC quality measures for surgical cases in Michigan. METHODS: In this retrospective cohort study, processes of care and outcomes for CRC resection cases were abstracted in 30 hospitals in the Michigan Surgical Quality Collaborative (2014-2015). Measures were case-mix and reliability adjusted, using logistic regression models. RESULTS: For 871 cases (640 colon cancer, 231 rectal cancer), adjusted morbidity (27.4%) and mortality rates (1.5%) were low. Adjusted process measures showed gaps in quality of care. Mesorectal excision was documented in 59.4% of rectal cancer (RC) cases, 65% of RC cases had sphincter preserving surgery, 18.7% of cases had < 12 lymph nodes examined, 7.9% had a positive margin, 52.1% of stage II/III RC cases had neoadjuvant therapy, and 36% of ostomy cases had site marking. CONCLUSION: This study finds gaps in quality of care measures for CRC, suggesting opportunity for regional quality improvement.
OBJECTIVE: Surgery remains the cornerstone therapy for colorectal cancer (CRC). This study assesses CRC quality measures for surgical cases in Michigan. METHODS: In this retrospective cohort study, processes of care and outcomes for CRC resection cases were abstracted in 30 hospitals in the Michigan Surgical Quality Collaborative (2014-2015). Measures were case-mix and reliability adjusted, using logistic regression models. RESULTS: For 871 cases (640 colon cancer, 231 rectal cancer), adjusted morbidity (27.4%) and mortality rates (1.5%) were low. Adjusted process measures showed gaps in quality of care. Mesorectal excision was documented in 59.4% of rectal cancer (RC) cases, 65% of RC cases had sphincter preserving surgery, 18.7% of cases had < 12 lymph nodes examined, 7.9% had a positive margin, 52.1% of stage II/III RC cases had neoadjuvant therapy, and 36% of ostomy cases had site marking. CONCLUSION: This study finds gaps in quality of care measures for CRC, suggesting opportunity for regional quality improvement.
Authors: Ruben Veldkamp; Esther Kuhry; Wim C J Hop; J Jeekel; G Kazemier; H Jaap Bonjer; Eva Haglind; Lars Påhlman; Miguel A Cuesta; Simon Msika; Mario Morino; Antonio M Lacy Journal: Lancet Oncol Date: 2005-07 Impact factor: 41.316
Authors: Samantha Hendren; Danielle Fritze; Mousumi Banerjee; James Kubus; Robert K Cleary; Michael J Englesbe; Darrell A Campbell Journal: Ann Surg Date: 2013-03 Impact factor: 12.969
Authors: Hari Nathan; Andrew D Shore; Robert A Anders; Elizabeth C Wick; Susan L Gearhart; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2010-12-21 Impact factor: 3.452
Authors: A J Breugom; P G Boelens; C B M van den Broek; A Cervantes; E Van Cutsem; H J Schmoll; V Valentini; C J H van de Velde Journal: Ann Oncol Date: 2014-03-26 Impact factor: 32.976
Authors: Pierre J Guillou; Philip Quirke; Helen Thorpe; Joanne Walker; David G Jayne; Adrian M H Smith; Richard M Heath; Julia M Brown Journal: Lancet Date: 2005 May 14-20 Impact factor: 79.321
Authors: Arielle E Kanters; Robert K Cleary; Shawn H Obi; Theodor Asgeirsson; Sarah K Evilsizer; Laurie G Fasbinder; Darrell A Campbell; Samantha K Hendren Journal: Dis Colon Rectum Date: 2020-01 Impact factor: 4.412
Authors: Ryan K Orosco; Viridiana J Tapia; Joseph A Califano; Bryan Clary; Ezra E W Cohen; Christopher Kane; Scott M Lippman; Karen Messer; Alfredo Molinolo; James D Murphy; John Pang; Assuntina Sacco; Kathryn R Tringale; Anne Wallace; Quyen T Nguyen Journal: Sci Rep Date: 2018-04-09 Impact factor: 4.379